As the spread of infectious diseases, current pandemic, and growing antimicrobial resistance (AMR) continues globally, next-generation sequencing (NGS) and specifically metagenomics became a tool to diagnose infectious diseases. Biotia’s comprehensive NGS test profiles the microbiome including bacteria, viruses, fungi, and parasites by leveraging our robust database including 16,000 microbial species, 3,000 AMR and 34,000 virulence factors. The rapid identification of pathogens providing key information on species, strains, virulence factors, and antimicrobial resistance markers. Biotia’s NGS and artificial intelligence-based approach enables emerging pathogen and strain identification, patient risk stratification, AMR tracking, clinical interpretation and outcome prediction.
1. Facilitate in-depth knowledge about harnessing microbial genetic information to develop breakthrough diagnostic tools
2. Leverage insights gathered from the microbiome and virome to fight against infectious diseases through the development of precision diagnostics